What is the significance of this filing being an amendment (10-K/A)?

An amendment to a 10-K filing means that McKesson Corporation is correcting or supplementing information that was previously filed in its original annual report. Investors should pay close attention to the specific changes made in the amendment, as they may represent important updates to the company's financial position, business operations, or risk disclosures.

What was McKesson Corporation's core business in 1999?

In 1999, McKesson Corporation was primarily engaged in the distribution of pharmaceuticals, medical supplies, and health and beauty care products. It was one of the largest companies in its sector, serving pharmacies, hospitals, and other healthcare providers.

Where can I find the specific financial details in this filing?

As this is an amended filing and the provided text is a directory listing, the actual financial statements and detailed business descriptions would be found within the document files such as '-99-001806.txt' or other linked documents within the EDGAR database. Investors would need to access the full text of the amendment to review specific financial figures and disclosures.

How relevant is this 1999 filing to McKesson's current business?

This filing is historical data. McKesson has undergone significant transformations, acquisitions, and divestitures since 1999. While it provides insight into the company's past, it is not directly indicative of its current financial performance, strategic direction, or market position. Investors should consult the most recent filings for up-to-date information.

MCK 10-K FY1999 Annual Report — Revenue, Net Income, EPS

Summary

McKesson Corporation's 10-K filing amendment from October 1999 provides an update on its financial performance and business operations for the period ending March 30, 1999. The filing primarily serves to amend previous disclosures, indicating a need for clarification or correction of information previously submitted. Investors should note that this filing reflects a period where McKesson was a major distributor of pharmaceuticals and healthcare products, a sector with ongoing regulatory and market dynamics.

Key Highlights

1This filing is an amendment (10-K/A) to a previous annual report, suggesting a revision or addition to initial disclosures.
2The period ending date is March 30, 1999, with the amendment filed on October 11, 1999.
3McKesson Corporation was a significant player in the pharmaceutical and healthcare distribution industry during this period.
4As an amendment, the filing might contain corrections, clarifications, or additional material information that investors should review.
5The filing is from 1999, so it reflects the company's status and market conditions at the turn of the millennium, which may differ significantly from its current operations.
6Investors should look for specific details within the amendment regarding financial statements, business segments, legal proceedings, or risk factors that were updated.

MCKESSON CORP Annual Report (Amendment), Year Ended Mar 31, 1999

Summary

Key Highlights

Frequently Asked Questions